Illumina placed on China’s unreliable entity list – MedTech Dive
Analysts said the move comes amid rising trade tensions with the U.S. and as Illumina faces stiff competition in China’s genome sequencing market.Read More
The Heartbeat of World events
Analysts said the move comes amid rising trade tensions with the U.S. and as Illumina faces stiff competition in China’s genome sequencing market.Read More